Terms: = Pancreatic cancer AND RHOH, TTF, 399, ENSG00000168421, ARHH, RhoH
146 results:
1. Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer.
Yang H; Cheng J; Zhuang H; Xu H; Wang Y; Zhang T; Yang Y; Qian H; Lu Y; Han F; Cao L; Yang N; Liu R; Yang X; Zhang J; Wu J; Zhang N
Cancer Cell; 2024 Apr; 42(4):535-551.e8. PubMed ID: 38593780
[TBL] [Abstract] [Full Text] [Related]
2. Effect of cancer cachexia on first-line chemotherapy in patients with advanced pancreatic cancer: a claims database study in Japan.
Furuse J; Osugi F; Machii K; Niibe K; Endo T
Int J Clin Oncol; 2024 Apr; 29(4):456-463. PubMed ID: 38353906
[TBL] [Abstract] [Full Text] [Related]
3. [Practical application of immunohistochemistry in pancreatic neuroendocrine neoplasms : Tips and pitfalls].
Bräutigam K; Chouchane A; Konukiewitz B; Perren A
Pathologie (Heidelb); 2024 Feb; 45(1):35-41. PubMed ID: 38175232
[TBL] [Abstract] [Full Text] [Related]
4. Genomic profile and clinical features of MSI-H and TMB-high pancreatic cancers: real-world data from C-CAT database.
Sakakida T; Ishikawa T; Doi T; Morita R; Kataoka S; Miyake H; Yamaguchi K; Moriguchi M; Sogame Y; Yasuda H; Iwasaku M; Konishi H; Takayama K; Itoh Y
J Gastroenterol; 2024 Feb; 59(2):145-156. PubMed ID: 38006445
[TBL] [Abstract] [Full Text] [Related]
5. [A case of primary lung metastatic pancreatic tumor resected following chemoradiotherapy].
Banjoya S; Tagaya N; Obana Y; Suzuki J; Suzuki J; Kurosaki T; Yamada N; Kaneko H; Imanishi M; Aoki I
Nihon Shokakibyo Gakkai Zasshi; 2023; 120(9):773-780. PubMed ID: 37690833
[TBL] [Abstract] [Full Text] [Related]
6. FOLFIRINOX in pancreatic cancer: Risk Factors for Febrile Neutropenia and Severe Neutropenia - Nationwide Study Analysis.
Todaka A; Sasaki M; Ueno H; Goto T; Murohisa G; Mizuno N; Ozaka M; Kobayashi S; Uesugi K; Kobayashi N; Hayashi H; Sudo K; Okano N; Horita Y; Kamei K; Nanami S; Boku N
Anticancer Res; 2023 Sep; 43(9):4115-4123. PubMed ID: 37648306
[TBL] [Abstract] [Full Text] [Related]
7. Minimally Invasive Hepatopancreatobiliary Surgery at a Large Regional Health System: Assessing the Safety of Program Expansion.
Falls SJ; Maxwell CM; Kaye DJ; Dighe SG; Schiffman SC; Bartlett DL; Wagner PL; Allen CJ
Am Surg; 2024 Jan; 90(1):85-91. PubMed ID: 37578387
[TBL] [Abstract] [Full Text] [Related]
8. DNA methylation-based classifier differentiates intrahepatic pancreato-biliary tumours.
Dragomir MP; Calina TG; Perez E; Schallenberg S; Chen M; Albrecht T; Koch I; Wolkenstein P; Goeppert B; Roessler S; Calin GA; Sers C; Horst D; Roßner F; Capper D
EBioMedicine; 2023 Jul; 93():104657. PubMed ID: 37348162
[TBL] [Abstract] [Full Text] [Related]
9. Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECIST.
de Mestier L; Resche-Rigon M; Dromain C; Lamarca A; La Salvia A; de Baker L; Fehrenbach U; Pusceddu S; Colao A; Borbath I; de Haas R; Rinzivillo M; Zerbi A; Funicelli L; de Herder WW; Selberherr A; Wagner AD; Manoharan P; De Cima A; Lybaert W; Jann H; Prinzi N; Faggiano A; Annet L; Walenkamp A; Panzuto F; Pedicini V; Pitoni MG; Siebenhuener A; Mayerhoefer ME; Ruszniewski P; Vullierme MP
J Neuroendocrinol; 2023 Jun; 35(6):e13311. PubMed ID: 37345276
[TBL] [Abstract] [Full Text] [Related]
10. Risk Factors and Outcomes of Open Conversion During Minimally Invasive Major Hepatectomies: An International Multicenter Study on 3880 Procedures Comparing the Laparoscopic and Robotic Approaches.
Montalti R; Giglio MC; Wu AGR; Cipriani F; D'Silva M; Suhool A; Nghia PP; Kato Y; Lim C; Herman P; Coelho FF; Schmelzle M; Pratschke J; Aghayan DL; Liu Q; Marino MV; Belli A; Chiow AKH; Sucandy I; Ivanecz A; Di Benedetto F; Choi SH; Lee JH; Park JO; Prieto M; Guzman Y; Fondevila C; Efanov M; Rotellar F; Choi GH; Robles-Campos R; Wang X; Sutcliffe RP; Tang CN; Chong CC; D'Hondt M; Dalla Valle B; Ruzzenente A; Kingham TP; Scatton O; Liu R; Mejia A; Mishima K; Wakabayashi G; Lopez-Ben S; Pascual F; Cherqui D; Forchino F; Ferrero A; Ettorre GM; Levi Sandri GB; Sugioka A; Edwin B; Cheung TT; Long TCD; Abu Hilal M; Aldrighetti L; Fuks D; Han HS; Troisi RI; Goh BKP;
Ann Surg Oncol; 2023 Aug; 30(8):4783-4796. PubMed ID: 37202573
[TBL] [Abstract] [Full Text] [Related]
11. Risk Factors of Positive Resection Margin in Hepatectomy for Resectable Ruptured Hepatocellular Carcinoma: Risk Prediction and Prognosis.
Xia F; Zhang Q; Zheng J; Huang Z; Ndhlovu E; Gao H
J Gastrointest Surg; 2023 Jul; 27(7):1400-1411. PubMed ID: 37095336
[TBL] [Abstract] [Full Text] [Related]
12. Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan.
Sakakida T; Ishikawa T; Doi T; Morita R; Kataoka S; Miyake H; Yamaguchi K; Moriguchi M; Sogame Y; Yasuda H; Iwasaku M; Konishi H; Takayama K; Itoh Y
J Gastroenterol; 2023 Jun; 58(6):575-585. PubMed ID: 37029223
[TBL] [Abstract] [Full Text] [Related]
13. Venous Thromboembolism in Patients with Advanced pancreatic cancer Receiving Palliative Chemotherapy: Incidence and Effect on Prognosis.
Jeong HT; Bae JH; Kim HG; Han J
Korean J Gastroenterol; 2023 Mar; 81(3):109-120. PubMed ID: 36960693
[TBL] [Abstract] [Full Text] [Related]
14. [Techniques and Short-Term Outcomes of Robotic pancreaticoduodenectomy].
Takeda Y; Ohmura Y; Katsura Y; Shinke G; Kinoshita M; Aoyama S; Kihara Y; Yanagisawa K; Katsuyama S; Ikeshima R; Hiraki M; Sugimura K; Masuzawa T; Hata T; Murata K
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1506-1508. PubMed ID: 36733117
[TBL] [Abstract] [Full Text] [Related]
15. FOLFOX-bevacizumab chemotherapy in patients with metastatic neuroendocrine tumors.
Lacombe C; Perrier M; Hentic O; Brixi H; De Rycke O; Cros J; Rebours V; Cadiot G; Ruszniewski P; de Mestier L
J Neuroendocrinol; 2023 Jan; 35(1):e13227. PubMed ID: 36599808
[TBL] [Abstract] [Full Text] [Related]
16. Efficacy and safety of no-touch radiofrequency ablation for small hepatocellular carcinoma-a systematic review and single-arm meta-analysis.
Du F; Zhang L; Zhang Y; Fan H; Ren L
Clin Res Hepatol Gastroenterol; 2023 Jan; 47(1):102069. PubMed ID: 36513251
[TBL] [Abstract] [Full Text] [Related]
17. A case report of anterior mediastinal signet ring cell carcinoma.
Liu S; Zhao A; Mao M
Medicine (Baltimore); 2022 Dec; 101(48):e32202. PubMed ID: 36482538
[TBL] [Abstract] [Full Text] [Related]
18. pancreatic cancer survival trends in the US from 2001 to 2014: a CONCORD-3 study.
Nikšić M; Minicozzi P; Weir HK; Zimmerman H; Schymura MJ; Rees JR; Coleman MP; Allemani C;
Cancer Commun (Lond); 2023 Jan; 43(1):87-99. PubMed ID: 36353792
[TBL] [Abstract] [Full Text] [Related]
19. Lung carcinoid tumours: histology and Ki-67, the eternal rivalry.
Centonze G; Maisonneuve P; Simbolo M; Lagano V; Grillo F; Fabbri A; Prinzi N; Garzone G; Filugelli M; Pardo C; Mietta A; Pusceddu S; Sabella G; Bercich L; Mangogna A; Rolli L; Grisanti S; Benvenuti MR; Pastorino U; Roz L; Scarpa A; Berruti A; Capella C; Milione M
Histopathology; 2023 Jan; 82(2):324-339. PubMed ID: 36239545
[TBL] [Abstract] [Full Text] [Related]
20. Biweekly TAS-102 and bevacizumab as third-line chemotherapy for advanced or recurrent colorectal cancer: a phase II, multicenter, clinical trial (TAS-CC4 study).
Matsuoka H; Yamada T; Ohta R; Yoshida Y; Watanabe T; Takahashi M; Kosugi C; Fukazawa A; Kuramochi H; Matsuda A; Sonoda H; Yoshida H; Hasegawa S; Sakamoto K; Otsuka T; Hirata K; Koda K;
Int J Clin Oncol; 2022 Dec; 27(12):1859-1866. PubMed ID: 36201089
[TBL] [Abstract] [Full Text] [Related]
[Next]
